Evidence map›Paper›PMID 39631408›Full record

ArticleBeneficial microbes2024

Bacillus subtilis DE111 partially reverses endothelial dysfunction in western-diet fed mice.

B D Risk, E L Graham, M Zhang, Y Wei, G C Stark, G D Brown, C L Gentile, T L Weir

Abstract read
In one paragraph

Article in Beneficial microbes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

B D RiskDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.ORCID https://orcid.org/0000-0002-8096-6993
E L GrahamDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
M ZhangDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
Y WeiDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
G C StarkDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
G D BrownDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
C L GentileDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
T L WeirDepartment of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.

Funding

The Obese Microbiota as a Novel Regulator of Vascular Function: A Translational ApproachR01HL144611 · NHLBI · COLORADO STATE UNIVERSITY · PI GENTILE, CHRISTOPHER L, WEIR, TIFFANY L · 2019 to 2022
$1.4M
NHLBI NIH HHS R01 HL144611
6 · The paper itself

Abstract

Imbalances in the gut microbiome have emerged as an important factor in endothelial dysfunction, a significant risk factor for cardiovascular disease. Thus, interventions targeting the microbiome may prove helpful in preventing or reversing this impairment. We previously reported that spore-forming Bacillus subtilis DE111 improved endothelial function in a cohort of healthy, non-obese humans after a four-week intervention. Building on these promising results, the present study sought to investigate whether administering B. subtilis DE111 could reverse endothelial dysfunction in mice with diet-induced obesity. Male C57BL/6J mice were fed a Western diet (WD; n = 24) or standard diet (SD; n = 24) for ten weeks to induce endothelial dysfunction, after which half of the animals in each group (n = 12) were allocated to receive B. subtilis DE111 (hereafter, PB) formulated into the diet for an additional eight weeks. Outcomes included endothelial-dependent arterial dilation, glucose tolerance, body weight changes, microbiota profiles, and assessments of intestinal permeability and mucosal immunity markers. Furthermore, a cell culture model of gut barrier function was used to assess the effects of PB on gut barrier integrity. PB treatment significantly attenuated WD-induced mesenteric endothelial-dependent arterial dilation, independent of changes in other cardiometabolic parameters or changes in gut barrier function. In vitro trans-epithelial electrical resistance of the Caco-2 cell culture confirmed that neither PB-conditioned media nor faecal waters from B. subtilis-treated human stool resulted in gut barrier improvements, nor did they protect against inflammation-associated barrier disruptions. Unsurprisingly, microbiota analysis revealed significant differences in Shannon's alpha diversity of WD-fed animals compared to SD. These data suggest that PB consumption significantly attenuated WD diet-induced endothelial dysfunction; however, the underlying mechanisms of this protection were not determined. Improvement in endothelial function was independent of PB-mediated changes to body weight or gut barrier function. Further studies should explore B. subtilis-mediated immune responses or metabolite production as mechanisms underlying these endothelial protective effects.

Indexed as

Bacillus subtilisDiet, WesternEndothelium, VascularObesityProbioticsAnimalsCaco-2 CellsFecesGastrointestinal MicrobiomeHumansIntestinal MucosaMaleMiceMice, Inbred C57BL

Identifiers

PMID39631408
PMCPMC13450210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.